Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Notes Payables (2016 - 2021)

Creative Medical Technology Holdings has reported Notes Payables over the past 8 years, most recently at $2.7 million for Q3 2021.

  • Quarterly Notes Payables rose 201.97% to $2.7 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Sep 2021, up 201.97% year-over-year, with the annual reading at $788701.0 for FY2020, 25.75% down from the prior year.
  • Notes Payables was $2.7 million for Q3 2021 at Creative Medical Technology Holdings, up from $105000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $2.7 million in Q3 2021 and troughed at $100000.0 in Q1 2017.
  • The 5-year median for Notes Payables is $682056.0 (2018), against an average of $667357.7.
  • Biggest five-year swings in Notes Payables: soared 763.53% in 2019 and later tumbled 89.97% in 2021.
  • Tracing CELZ's Notes Payables over 5 years: stood at $125000.0 in 2017, then surged by 445.64% to $682056.0 in 2018, then soared by 55.74% to $1.1 million in 2019, then fell by 25.75% to $788701.0 in 2020, then skyrocketed by 247.84% to $2.7 million in 2021.
  • According to Business Quant data, Notes Payables over the past three periods came in at $2.7 million, $105000.0, and $327225.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.